Evercore ISI Starts Apnimed Inc. (APMD) at Outperform Aug 25, 2026 06:03AM
Evercore ISI Starts Alvotech SA (ALVO) at Outperform Aug 14, 2026 07:14AM
Evercore ISI Starts Parabilis Medicines (PBLS) at Outperform Jul 6, 2026 06:04AM
Evercore ISI Reinstates Biogen (BIIB) at Outperform May 14, 2026 04:59PM
Evercore ISI Starts Kailera Therapeutics (KLRA) at Outperform May 12, 2026 06:32AM
View Older Stories

May 4, 2026 08:44AM Why Eli Lilly stock is down 3% today: FDA adverse event data explained
Mar 31, 2026 08:00AM Enveda Reports Positive Results for ENV-294 in a Phase 1b Clinical Trial of Patients with Moderate-to-Severe Atopic Dermatitis
Feb 2, 2026 06:00AM IDEAYA Biosciences to Participate in Upcoming February 2026 Investor Relations Events
Jan 6, 2026 08:18AM Evercore ISI on Vaxcyte (PCVX): 'vaccine shakeup, but there's no change to PCV recs...'
Nov 25, 2025 08:00AM Evercore Hosts 8th Annual Healthcare Conference, Dec. 2-4, 2025
Nov 20, 2025 08:00AM Shattuck Labs to Participate in Upcoming December Investor Conferences
Nov 6, 2025 10:00AM Life Sciences, TechBio, and Investment Leaders at Demy-Colton’s BioFuture™ 2025 Suggest Health and Biotech Sectors Show Signs of New Life
Oct 28, 2025 07:00AM Evercore ISI Ranked No. 1 in Extel All-America Research Survey for 4th Straight Year
Sep 23, 2025 10:00AM BioFuture™ 2025 Explores the Next Era of Innovation, Policy, and Investment in Biopharma
Jun 23, 2025 07:00AM Skye Bioscience Shares Nimacimab “Anatomy of Progress” Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association’s 85th Scientific Sessions
Feb 20, 2025 12:50PM Eli Lilly bets big on weight-loss pill with $550 million inventory stockpile
Nov 4, 2024 06:03AM Analysis-Americans hungry for weight-loss drugs grapple with supply and insurance hurdles
Oct 29, 2024 07:15AM Evercore ISI Recognized as the #1 Firm in U.S. Equity Research for the Third Consecutive Year
Jul 16, 2024 07:02AM Evercore ISI Starts Spyre (SYRE) at Outperform
Jun 14, 2024 11:40AM Evercore ISI on Gilead (GILD): 'Gilead isn’t hyping it etc, the conversation flow was us reaching out to Gilead to clarify, rather than Gilead flagging it to everyone'
May 2, 2024 04:02PM Amgen 'encouraged' by weight-loss drug interim data, shares jump
Mar 8, 2024 09:27AM Evercore ISI Downgrades Amylyx Pharmaceuticals inc. (AMLX) to In Line
Feb 28, 2024 08:03AM Evercore ISI Starts Fractyl Health Inc (GUTS) at Outperform
Feb 27, 2024 08:00AM Frontier Medicines to Participate in Upcoming Investor Conferences
Feb 16, 2024 06:23AM Evercore ISI Starts Rapt Therapeutics (RAPT) at Outperform, 'risk reward is very good at these levels'
Jan 29, 2024 11:34AM Pharma price cut proposals from US government could be steep, analysts say
Jan 22, 2024 12:43PM Gilead drops 11% after lung cancer drug trial fails, analyst says stock is 'overreacting'
Dec 11, 2023 01:55PM Analyst says buy the pullback in obesity stocks as today's report refers to old data
Oct 24, 2023 08:00AM Evercore ISI Recognized as the Top-Ranked Firm in U.S. Equity Research for the Second Consecutive Year
Oct 24, 2023 07:52AM Evercore ISI Upgrades Alkermes (ALKS) to Outperform, 'down 10%? I wouldn’t have thought so'
Sep 29, 2023 03:22PM Around 1.8 million Americans received COVID shots last week -IQVIA
Jul 17, 2023 09:08AM Evercore ISI Remains Positive on Apellis Pharmaceuticals (APLS)
Jun 2, 2023 08:06AM Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
May 30, 2023 08:12AM Evercore ISI on Pfizer (PFE): 'Hard to ignore the d-dimer findings with Pfizer TFPI'
May 18, 2023 07:55AM Evercore ISI Upgrades Teva Pharma (TEVA) to Outperform, 'TL1A & pipeline in focus'
Feb 9, 2023 12:16PM Evercore's DiFiore on Amylyx Pharmaceuticals inc. (AMLX) ALS Relyvrio Launch: 'I feel very confident in launch and remain very constructive'
Jan 20, 2023 12:04PM Evercore ISI Says Gilead Sciences (GILD) Tenofovir Risk 'waning'
Dec 19, 2022 11:03AM Evercore Says Cerevel Therapeutics Holdings (CERE) BP Results are 'Very Positive'
Nov 17, 2022 01:52PM Bausch Health (BHC): FDA Added Extra Hurdle for Generic Xifaxan - Evercore ISI
Nov 17, 2022 08:00AM Inspirna to Present at the Evercore ISI Annual HealthCONx Conference
Oct 25, 2022 08:00AM Evercore ISI Recognized as the Top-Ranked Firm in U.S. Equity Research
May 6, 2022 09:35AM UPDATE: Evercore ISI Downgrades Phathom Pharmaceuticals (PHAT) to In Line
Oct 26, 2021 08:00AM Evercore ISI Recognized as the Top Ranked Independent Firm in U.S. Equity Research
Sep 17, 2021 12:32PM Moderna (MRNA), BioNTech (BNTX) Hit Session Low Amid Doubt FDA Will Back Vaccine Booster
Jul 15, 2021 08:00AM Prometheus Biosciences to Host Virtual R&D Day for Investors on July 28, 2021
Jul 15, 2021 08:00AM Prometheus Biosciences to Host Virtual R&D Day for Investors on July 28, 2021
Jun 4, 2021 07:48AM Investors, patients await FDA decision on Biogen Alzheimer's drug due Monday
Mar 9, 2021 11:59AM Januvia IP an under-the-radar catalyst for Merck (MRK) - Evercore ISI
Nov 25, 2020 01:28PM Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference
Nov 25, 2020 01:28PM Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference
Nov 25, 2020 08:08AM Evercore ISI Starts Atea Pharmaceuticals (AVIR) at Outperform
Nov 23, 2020 08:00AM RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences
Nov 23, 2020 07:45AM Evercore ISI Starts Arcus Biosciences (RCUS) at Outperform
Oct 21, 2020 06:00AM Evercore ISI Recognized as the Top Ranked Independent Firm in U.S. Equity Research
Jan 21, 2020 09:15AM Evercore ISI Upgrades Amgen (AMGN) to Outperform
View Older Stories